Embecta (EMBC) Return on Capital Employed (2021 - 2026)
Embecta's (EMBC) quarterly Return on Capital Employed came in at 33.63% in Q1 2026, up 1379.0% year-on-year from 2.27% in Q1 2025, and down 4.48% quarter-over-quarter from 35.21% in Q4 2025.
Embecta (EMBC) Return on Capital Employed (2021 - 2026) Analysis & Trends
Embecta has disclosed Return on Capital Employed across 6 years of filings, most recently posting 33.63% for Q1 2026.
- Return on Capital Employed for Q1 2026 came in at 33.63%, up 1379.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 33.63% (up 1379.0% YoY), and the FY2025 annual result was 26.13%, up 708.0% from the prior year.
- Return on Capital Employed came in at 33.63% for Q1 2026 at Embecta, down from 35.21% in the prior quarter.
- In the past five years, Return on Capital Employed ranged from a high of 73.97% in Q1 2022 to a low of 16.32% in Q4 2024.
- The 5-year median for Return on Capital Employed is 25.18% (2023), against an average of 30.63%.
- Across the five-year window, Return on Capital Employed slumped 4577 bps in 2023 and surged 1889 bps in 2025, its largest moves.
- Embecta's Return on Capital Employed stood at 36.53% in 2022, then tumbled by 45 bps to 20.03% in 2023, then decreased by 19 bps to 16.32% in 2024, then jumped by 116 bps to 35.21% in 2025, then slipped by 4 bps to 33.63% in 2026.
- The last three Return on Capital Employed figures came in at 33.63% (Q1 2026), 35.21% (Q4 2025), and 28.07% (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn | 17.54% |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn | 5.02% |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn | - |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn | 25.95% |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn | 18.63% |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn | 19.44% |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn | 4.68% |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn | 12.74% |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn | 13.02% |
| 10 | Embecta | 183.23 Mn | -10.17 Mn | 127.80 Mn | 33.63% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 33.63% |
| Dec 31, 2025 | 35.21% |
| Sep 30, 2025 | 28.07% |
| Jun 30, 2025 | 24.54% |
| Mar 31, 2025 | 19.84% |
| Dec 31, 2024 | 16.32% |
| Sep 30, 2024 | 18.48% |
| Jun 30, 2024 | 19.28% |
| Mar 31, 2024 | 18.01% |
| Dec 31, 2023 | 20.03% |
| Sep 30, 2023 | 25.18% |
| Jun 30, 2023 | 22.80% |
| Mar 31, 2023 | 28.20% |
| Dec 31, 2022 | 36.53% |
| Sep 30, 2022 | 40.36% |
| Jun 30, 2022 | 60.27% |
| Mar 31, 2022 | 73.97% |
| Dec 31, 2021 | 80.10% |